Treating Refractory Idiopathic Thrombocytopenic Purpura (ITP)
In this segment, Howard A. Liebman, MD, and Keith McCrae, MD, describe various treatment strategies in refractory idiopathic thrombocytopenic purpura (ITP).
▶︎
Immune Thrombocytopenia (ITP): Advances in Treatment in 2020
▶︎
Thrombotic thrombocytopenic purpura (TTP): Why it’s important to understand it
▶︎
2022 ITP Association Dr Pip Nicolson talks about IVIG Treatment for ITP
▶︎
Managing and Treating Polycythemia Vera (PV)
▶︎
SSBMT Webinar Series - How I Treat Refractory ITP with Dr. Waleed Ghanima of University of Oslo
▶︎
Treating Persistent/Chronic ITP - Current Care, Future Potential
▶︎
Behind the Mystery of Chronic Immune Thrombocytopenia (ITP): A Blood Platelet Disorder
▶︎
Thrombotic thrombocytopenic purpura (NORD)
▶︎
Testimony Thursday - I Was Healed Of A Disease With No Cure (ITP)
▶︎
Immune Thrombocytopenia (ITP) — Most COMPREHENSIVE Explanation — Hematology
▶︎
Fostamatinib as Second-Line ITP Therapy
▶︎
TAVALISSE CLINICAL CORNER (9/20/18)
▶︎
Platelet Disorders and ITP (updated 2023) - CRASH! Medical Review Series
▶︎
Idiopathic guttate hypomelanosis - a review with emphasis on treatment
▶︎
Living with ITP: Marie Louise's story
▶︎
Thrombocytopenia
▶︎
Thrombotic Thrombocytopenic Purpura (TTP/HUS) - CRASH! Medical Review Series
▶︎
Risk of Thrombosis in Patients With ITP
▶︎
Over 60? Drink THIS to BOOST Blood Flow in Legs Fast || Dr. Alan Mandell
▶︎